DIPNA PHARMACHEM | GOYAL ALUMINIUMS | DIPNA PHARMACHEM/ GOYAL ALUMINIUMS |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | 62.9 | - | View Chart |
P/BV | x | 0.4 | 6.9 | 6.3% | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
DIPNA PHARMACHEM GOYAL ALUMINIUMS |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DIPNA PHARMACHEM Mar-24 |
GOYAL ALUMINIUMS Mar-24 |
DIPNA PHARMACHEM/ GOYAL ALUMINIUMS |
5-Yr Chart Click to enlarge
|
||
High | Rs | 29 | 48 | 61.7% | |
Low | Rs | 9 | 7 | 130.0% | |
Sales per share (Unadj.) | Rs | 68.3 | 48.0 | 142.4% | |
Earnings per share (Unadj.) | Rs | 0.5 | 1.6 | 27.7% | |
Cash flow per share (Unadj.) | Rs | 0.5 | 1.8 | 25.4% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 15.6 | 14.0 | 111.3% | |
Shares outstanding (eoy) | m | 24.05 | 14.27 | 168.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.3 | 0.6 | 49.6% | |
Avg P/E ratio | x | 42.9 | 16.8 | 254.7% | |
P/CF ratio (eoy) | x | 42.2 | 15.2 | 278.3% | |
Price / Book Value ratio | x | 1.2 | 2.0 | 63.5% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 465 | 391 | 119.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 5 | 3 | 173.2% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,643 | 685 | 240.0% | |
Other income | Rs m | 0 | 3 | 1.5% | |
Total revenues | Rs m | 1,643 | 687 | 239.1% | |
Gross profit | Rs m | 35 | 33 | 106.1% | |
Depreciation | Rs m | 0 | 3 | 6.7% | |
Interest | Rs m | 21 | 2 | 1,240.7% | |
Profit before tax | Rs m | 14 | 31 | 45.2% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 3 | 8 | 40.8% | |
Profit after tax | Rs m | 11 | 23 | 46.7% | |
Gross profit margin | % | 2.1 | 4.8 | 44.2% | |
Effective tax rate | % | 23.5 | 26.1 | 90.2% | |
Net profit margin | % | 0.7 | 3.4 | 19.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 1,329 | 172 | 774.0% | |
Current liabilities | Rs m | 828 | 36 | 2,276.4% | |
Net working cap to sales | % | 30.4 | 19.8 | 154.1% | |
Current ratio | x | 1.6 | 4.7 | 34.0% | |
Inventory Days | Days | 0 | 32 | 0.0% | |
Debtors Days | Days | 687 | 74,441 | 0.9% | |
Net fixed assets | Rs m | 0 | 65 | 0.6% | |
Share capital | Rs m | 240 | 143 | 168.5% | |
"Free" reserves | Rs m | 135 | 57 | 235.5% | |
Net worth | Rs m | 375 | 200 | 187.7% | |
Long term debt | Rs m | 125 | 1 | 16,509.2% | |
Total assets | Rs m | 1,329 | 237 | 560.8% | |
Interest coverage | x | 1.7 | 19.8 | 8.5% | |
Debt to equity ratio | x | 0.3 | 0 | 8,797.4% | |
Sales to assets ratio | x | 1.2 | 2.9 | 42.8% | |
Return on assets | % | 2.4 | 10.5 | 22.6% | |
Return on equity | % | 2.9 | 11.6 | 24.9% | |
Return on capital | % | 7.0 | 16.5 | 42.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -54 | 6 | -861.2% | |
From Investments | Rs m | NA | -33 | 0.5% | |
From Financial Activity | Rs m | 136 | NA | -50,433.3% | |
Net Cashflow | Rs m | 82 | -27 | -302.5% |
Indian Promoters | % | 10.0 | 70.0 | 14.3% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 90.0 | 30.0 | 299.8% | |
Shareholders | 2,652 | 64,359 | 4.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare DIPNA PHARMACHEM With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA UNIPHOS ENT
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DIPNA PHARMACHEM | GOYAL ALUMINIUMS | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.00% | -1.93% | 0.11% |
1-Month | -12.34% | 1.57% | -3.22% |
1-Year | -47.67% | 6.37% | 42.65% |
3-Year CAGR | -41.32% | 19.37% | 19.86% |
5-Year CAGR | -27.37% | 18.96% | 25.90% |
* Compound Annual Growth Rate
Here are more details on the DIPNA PHARMACHEM share price and the GOYAL ALUMINIUMS share price.
Moving on to shareholding structures...
The promoters of DIPNA PHARMACHEM hold a 10.0% stake in the company. In case of GOYAL ALUMINIUMS the stake stands at 70.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DIPNA PHARMACHEM and the shareholding pattern of GOYAL ALUMINIUMS.
Finally, a word on dividends...
In the most recent financial year, DIPNA PHARMACHEM paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
GOYAL ALUMINIUMS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of DIPNA PHARMACHEM, and the dividend history of GOYAL ALUMINIUMS.
For a sector overview, read our pharmaceuticals sector report.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.